AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company
HONG KONG, April 8, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced on April 7, 2025 that the company's research and development of the serum-free iterative rabies vaccine has received an "Acceptance...
Global Fab Equipment Investment Expected to Reach $110 Billion in 2025
MILPITAS, Calif., March 25, 2025 /PRNewswire/ -- Global fab equipment spending for front-end facilities in 2025 is anticipated to increase by 2% year-over-year (YoY) to $110 billion, marking the sixth consecutive year of growth since 2020, SEMI...
Jacobio Pharma Announces 2024 Annual Results
BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320...
Amcor prices private offering of $2.2 billion of senior unsecured notes
ZURICH, March 13, 2025 /PRNewswire/ -- Amcor plc (NYSE:AMCR; ASX:AMC) ("Amcor") announced today that Amcor Flexibles North America, Inc. ("AFNA"), a wholly-owned subsidiary of Amcor, has priced a private offering (the "Offering") of guaranteed...
Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update
ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing. ASC30...
ITALY, SIGEP WORLD, THE GLOBAL FOODSERVICE COMMUNITY'S LEADING SHOW, IS ABOUT TO START: 1,300 BRANDS
Trends, innovation, technologies and now also pizza at Italian Exhibition Group's 46th edition featuring sustainable sector initiatives in the name of internationality, at Rimini Expo Centre from 18th to 22nd January RIMINI, Italy, Jan. 14, 2025...
IBM Study: AI Spending Expected to Surge 52% Beyond IT Budgets as Retail Brands Embrace Enterprise-Wide Innovation
The report found that 81% of surveyed executives and 96% of their teams are already using AI to a moderate or significant extent Executives indicate they want to expand into more sophisticated AI use cases, such as integrated business planning where...